Orygen welcomes NHMRC's evidence-based interim advice on puberty suppressants

Orygen welcomes NHMRC's evidence-based interim advice on puberty suppressants

19 November 2026

Orygen welcomes the release of interim advice from the National Health and Medical Research Council (NHMRC) on the use of puberty suppressants in the care of trans and gender diverse young people.

Released for public consultation on 16 November, the advice is informed by a systematic review of the available scientific evidence, alongside the expertise of clinicians, researchers and people with lived experience. The rigorous two-year process was supported by a comprehensive governance structure, including a committee comprising experts in bioethics, health law and systematic reviews, and a reference panel representing young people, families and clinicians.

As a youth mental health research institute, Orygen strongly supports the development of national clinical guidelines grounded in the best available evidence, as well as expertise in clinical care, lived experience and human rights. We also welcome Federal Health Minister Mark Butler’s endorsement of the new advice.

The NHMRC's advice includes a conditional recommendation – recognition that different choices will be appropriate for different people – that puberty suppressants can be considered as a treatment option for trans and gender diverse young people aged under 18. It also recognises that treatment decisions must reflect each young person's individual needs, circumstances and preferences.

It emphasises the importance of comprehensive assessment, informed and shared decision-making involving young people, their parents or carers and treating clinicians, and appropriate ongoing care and monitoring.

Australian research has found that trans and gender diverse young people experience significantly higher rates of depression, anxiety and suicidal behaviour than their peers, highlighting the importance of accessible, safe and appropriate healthcare. Orygen recognises the importance of ensuring trans and gender diverse young people have the right to feel safe, respected and supported when seeking healthcare, including mental health support.

We support approaches that place young people's wellbeing at the centre of care, informed by the best available evidence, delivered in partnership with young people and their families, and upholding the rights of Australians to be involved in making decisions about their own care.

The NHMRC's advice is open for public consultation until 18 January 2027 and will inform the development of broader national clinical guidelines for the care of trans and gender diverse young people.